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Abstract 27 
Dietary isothiocyanates (ITCs) are potent inducers of the NF-E2-related factor-2 (Nrf2) 28 
pathway. Sulforaphane (SFN), a representative ITC, has previously been shown to 29 
upregulate antioxidant enzymes such as selenium (Se) dependent thioredoxin reductase-1 30 
(TrxR-1) in many tumour cell lines. In the present study, we hypothesized that a 31 
combination of SFN and Se would have a synergistic effect on the upregulation of TrxR-1 32 
and the protection against oxidative damage in the normal colonic cell line CCD841. 33 
Treatment of cells with SFN and Se significantly induced TrxR-1 expression. Pre-treatment 34 
of cells with SFN protects against H2O2-induced cell death; this protection was enhanced by 35 
co-treatment with Se. The siRNA knockdown of either TrxR-1 or Nrf2 reduced the 36 
protection afforded by SFN and Se co-treatment; TrxR-1 and Nrf2 knockdown reduced cell 37 
viabilities to 66.5 and 51.1% respectively, down from 82.4% in transfection negative 38 
controls. This suggests that both TrxR-1 and Nrf2 are important in SFN-mediated protection 39 
against free radical-induced cell death. Moreover, flow cytometric analysis showed that 40 
TrxR-1 and Nrf2 were involved in SFN-mediated protection against H2O2-induced 41 
apoptosis. In summary, SFN activates the Nrf2 signaling pathway and protects against 42 
H2O2-mediated oxidative damage in normal colonic cells. Combined SFN and Se treatment 43 
resulted in a synergistic upregulation of TrxR-1 that in part contributed to the enhanced 44 
protection against free radical-mediated cell death provided by the co-treatment.  45 
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1. Introduction 49 
 50 
Some early epidemiological studies suggest that intake of cruciferous vegetables is inversely 51 
correlated with the morbidity of various cancers including those of the lung, bladder and 52 
colon [1, 2]. However, the results of other epidemiological studies are inconsistent and 53 
inconclusive [3, 4]. Since cruciferous vegetables are rich sources of glucosinolates, it is 54 
inevitable that their chemoprotective activity is attributed to the isothiocyanates (ITCs). 55 
ITCs, derived from the glucosinolates in cruciferous vegetables, have in themselves 56 
significant cancer chemopreventive potential [5]. Among all the ITCs, sulforaphane (SFN), 57 
which is derived from glucoraphanin - commonly found in broccoli and cauliflower - has 58 
been the most intensively studied ITC in relation to cancer prevention. Administration of 59 
crucifers or ITCs to experimental animals has been shown to inhibit the development of 60 
colonic aberrant crypt foci [6] and to reduce the incidence and multiplicity of chemical-61 
induced tumors, including those of the bladder and colon [7, 8]. ITCs are potent inducers of 62 
phase II enzymes, which are involved in detoxifying potential endogenous and exogenous 63 
carcinogens [9, 10]. Importantly, ITCs have been shown to exert antioxidant effects via the 64 
regulation of NF-E2-related factor-2 (Nrf2)-antioxidant responsive element (ARE) 65 
pathways [11]. Nrf2 regulates a major cellular defence mechanism, and its activation is 66 
important in cancer prevention [12]. However, overexpression of Nrf2 in cancer cells 67 
protects them against the cytotoxic effects of anticancer therapies, thus promoting chemo-68 
resistance [13, 14]. Thioredoxin reductase 1 (TrxR-1) is an Nrf2-driven antioxidant enzyme, 69 
and it has been shown to play a dual role in cancer [15]. We have previously shown that 70 
TrxR-1 plays an important role in the protection against free radical-mediated cell death in 71 
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cultured normal and tumour cells [16, 17]. Moreover, the induction of TrxR-1 and 72 
glutathione peroxidase-2 (GPx2) by SFN is synergistically enhanced by selenium (Se) co-73 
treatment in colon cancer Caco-2 cells [18]. 74 
The mechanisms by which ITCs act in cancer prevention may involve multiple targeted 75 
effects, including the induction of phase II antioxidant enzymes, cell cycle arrest, and 76 
apoptosis [19, 20]. Other potential targets include kinases, transcriptional factors, 77 
transporters and receptors [21-24]. Since both Nrf2 and TrxR-1 can play dual roles in cancer 78 
[25-28], the benefits or risks of Nrf2 activation or TrxR-1 induction may depend upon the 79 
nature of the cells (normal vs. tumor). Therefore, it is important to investigate the effects of 80 
ITCs on normal cells. We hypothesized that a combination of SFN and Se would have a 81 
synergistic effect on the upregulation of TrxR-1 and on the protection against oxidative 82 
damage in the normal colonic cell line CCD841. Recently, we demonstrated that SFN 83 
promoted cancer cell proliferation, migration and angiogenesis at low concentrations 84 
(<2.5µM), whilst demonstrating opposite effects at high concentrations (>10µM) [29]. 85 
Activation of Nrf2 signalling and TrxR-1 in normal cells may be beneficial, and this effect 86 
is associated with the chemoprotective activity of SFN. In the present study, we have 87 
demonstrated that pre-treatment of cells with SFN and Se protects against free radical-88 
mediated cell death in normal colon epithelial CCD841 cells.89 
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2. Methods and materials 90 
 91 
2.1. Materials 92 
Sulforaphane (1-isothiocyanato-4-(methylsulfinyl)-butane, purity 98%) was purchased from 93 
Alexis Biochemicals (Exeter, EXETER UK). Sodium selenite (purity 98%), 94 
dimethylsulfoxide (DMSO), thioredoxin reductase, hydrogen peroxide and Bradford reagent 95 
were all purchased from Sigma (Sigma-Aldrich. Dorset, UK). Complete protease inhibitors 96 
were obtained from Roche Applied Science (West Sussex UK). Rabbit polyclonal primary 97 
antibodies to Nrf2 and TrxR-1, goat polyclonal primary antibody to β-actin, rabbit 98 
polyclonal primary antibody to the RNA-binding protein, Sam68, HRP-conjugated goat 99 
anti-rabbit, and rabbit anti-goat IgG were all purchased from Santa Cruz Biotechnology 100 
(Santa Cruz, Germany). The siRNAs for Nrf2 (Cat No. SI03246950, target sequence, 5′-101 
CCCATTGATGTTTCTGATCTA-3′), TrxR-1 (Cat No. SI00050876, target sequence, 5′-102 
CTGCAAGACTCTCGAAATTAT-3′), and AllStars Negative Control siRNA (AS) were all 103 
purchased from Qiagen (West Sussex, UK). The Annexin V-FITC apoptosis detection kit 104 
was purchased from eBioscience (Hatfield, Hertfordshire, UK). Electrophoresis and Western 105 
blotting supplies were obtained from Bio-Rad (Hertfordshire, UK), and the 106 
chemiluminescence kit was from GE Healthcare (Little Chalfont, Bucks UK). 107 
Alignment  108 
2.2. Cell culture 109 
CCD841 cells were cultured in DMEM supplemented with fetal bovine serum (10%), 2mM 110 
glutamine, penicillin (100 U/ml) and streptomycin (100µg/ml) under 5% CO2 in air at 37oC. 111 
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When the cells achieved 70-80% confluence, they were exposed to various concentrations 112 
of SFN and/or Se for different times with DMSO (0.1%) as control.  113 
 114 
2.3. Cell viability and apoptosis assays 115 
The cell proliferation MTT (3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide) 116 
assay was employed to determine the toxicity of SFN (1-160µM) and H2O2 (100-1600µM) 117 
towards cultured CCD841 cells. Cells were seeded on 96-well plates at a density of 1.0×104 118 
per well in DMEM with 10% FCS. When cells were at approximately 70–80% confluence, 119 
they were exposed to SFN at various concentrations for different times, using DMSO 120 
(0.1%) only as control. After all treatments, the medium was removed and then MTT 121 
(5mg/ml) was added, and incubated with the cells at 37°C for 1 h to allow the MTT to be 122 
metabolized. Then supernatant was removed and the produced formazan crystals were 123 
dissolved in DMSO (100μl per well). The final absorbance in the wells was recorded using a 124 
microplate reader (BMG Labtech Ltd, Aylesbury, Bucks, UK), at a wavelength of 550-125 
570nm and a reference wavelength of 650-670nm. 126 
 127 
     For apoptosis analysis, CCD841 cells were seeded on 12-well plates at a density of 128 
5.0×104 cells per well and incubated at 37°C for 48 h. After treatment with 2.5μM SFN 129 
and/or 0.1µM Se for 24 h, cells were exposed to 100-150µM H2O2 for 24 h. Cells were then 130 
trypsinized and collected by centrifugation at 180 g for 5 min at room temperature. The 131 
pellet was washed with cold PBS before being re-suspended in binding buffer at a cell 132 
density adjusted to 2.0-5.0×105/ml according to the instructions from the Annexin V-FITC 133 
apoptosis detection kit (eBiosciences, UK). Annexin V-FITC (fluorescein isothiocyanate) 134 
was used to stain for the apoptotic cells and propidium iodide (PI) used to stain the necrotic 135 
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cells. For each sample, 10,000 events were collected and the data were analysed using the 136 
FlowJo software (Tree Star Inc. Ashland, OR, USA). 137 
 138 
2.4. Knockdown of Nrf2 and TrxR-1 by siRNA 139 
 140 
CCD841 cells were seeded on 12-well plates in DMEM with 10% FCS. After 24 h, the cells 141 
were transfected with siRNA targeting Nrf2 or TrxR-1. Briefly, the cell medium was 142 
replaced with 1000µl 12% FCS medium, then 20nM siRNA and 6µl HiPerFect transfection 143 
reagent were combined in 100µl medium (without serum and antibiotics) and incubated at 144 
room temperature for 10 min, and then gently added drop-wise to the cells. AllStars 145 
Negative Control siRNA was used as a negative control (this siRNA has no homology to 146 
any known mammalian gene). After 24 h incubation with siRNA, SFN and Se were added in 147 
fresh medium for a further 24 h, then the effects of H2O2 (150µM, 24 h) on cell viability and 148 
apoptosis were measured using flow cytometric analysis. 149 
 150 
2.5. Protein extraction and immunoblotting of Nrf2 and TrxR-1 151 
To extract total protein, CCD841 cells were washed twice with ice-cold PBS, then harvested 152 
by scraping in 20mM Tris-HCl (pH 8), 150mM NaCl, 2mM EDTA, 10% glycerol, 1% 153 
Nonidet P-40 (NP-40) containing mini-complete proteinase inhibitor and 1mM PMSF, in an 154 
ice bath for 20 min to lyse cells. Then the lysate was centrifuged at 12,000 g for 15 min at 155 
4oC and the protein-containing supernatant was collected. To extract nuclear protein, the 156 
Nuclear Extract Kit (Active Motif, Rixensart, Belgium) was used, following the 157 
manufacturer’s instructions. Protein concentrations were determined by the Brilliant Blue G 158 
dye-binding assay of Bradford, using BSA as a standard. 159 
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    Protein extracts were heated at 95°C for 5 min in loading buffer and then loaded onto 160 
10% SDS-polyacrylamide gels together with a molecular weight marker. After routine 161 
electrophoresis and transfer to PVDF membranes, membranes were blocked with 5% fat 162 
free milk in Phosphate Buffered Saline Tween-20 (PBST) (0.05% Tween 20) for 1 h at room 163 
temperature, and then with specific primary antibodies against Nrf2 or TrxR-1 (diluted in 164 
5% milk in PBST) overnight at 4°C. Membranes were then washed four times for 40 min 165 
with PBST, then incubated with secondary antibodies (diluted in 5% milk in PBST) for 1 h 166 
at room temperature. After four further washes for 40 min with PBST, antibody binding was 167 
detected using an ECL kit (GE Healthcare), and the density of each band was measured with 168 
the FluorChem Imager (Alpha Innotech, San Leandro, CA), or the Li-Cor Odyssey Imager 169 
(Li-Cor Biotechnology UK Ltd, Cambridge, UK ). 170 
2.6. Statistics 171 
Data are represented as the means ± SD. The differences between the groups were examined 172 
using the one-way ANOVA/LSD test, or Student’s t-test. A p value <0.05 was considered 173 
statistically significant. IC50 values of SFN and H2O2 were determined using the CalcuSyn 174 
software (Biosoft, Cambridge, UK). 175 
176 
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3. Results  177 
 178 
3.1. Effect of SFN on cell growth. 179 
SFN has been shown to promote the growth of some tumor cell lines at low concentrations, 180 
but to be toxic to the same cells at higher concentrations through the induction of stress-181 
related cell cycle arrest and apoptosis [29-31]. CCD841 cells were cultured in 96-well plates 182 
(seeding 5.0×103 cells per well) and treated with SFN for 24 or 48 h once they reached 70-183 
80% confluence. In this study, 2.5 and 5µM SFN moderately stimulated the growth of 184 
CCD841 cells. 24 h treatment with 2.5 and 5μM SFN increased cell viability by 13 and 15% 185 
respectively versus control, while 48 h treatment with the same concentrations did so by 25 186 
and 11% respectively (Fig. 1). Treatment with higher concentrations of SFN (20-160µM) 187 
significantly reduced cell viability. SFN had IC50 values of 30.0µM (24 h) and 40.4μM (48 188 
h) for CCD841 cells. In contrast, the IC50 values of SFN for Caco-2 were 47.1μM (24 h) and 189 
50.6μM (48 h) as reported previously [18], suggesting that normal colonic cells are more 190 
susceptible to SFN-induced cell death. 191 
 192 
 193 
3.2. Effect of SFN on nuclear accumulation of Nrf2 194 
Untreated CCD841 cells exhibited very low Nrf2 levels in both the cytoplasm and the 195 
nucleus, consistent with the degradation of Nrf2 by proteasomes in a Keap1-dependent 196 
manner under homeostasis [32]. However, upon SFN treatment (1.25-40µM for 4 h), a 197 
significant increase of Nrf2 in the nucleus was observed, suggesting the rapid liberation of 198 
Nrf2 from Keap1-coupled suppression and its subsequent nuclear translocation (Fig. 2A) 199 
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[33]. However, SFN at 40μM showed less effect in this regard than at lower doses (2.5-200 
20µM), indicating a toxic effect at high concentrations. SFN at 1.25-20μM induced a 201 
significant and dose-dependent translocation of Nrf2 into the nucleus, resulting in nuclear 202 
levels 5.3-8.4 fold in magnitude versus controls. In the time course experiment, the level of 203 
Nrf2 in the nucleus peaked at 1 h following SFN (10μM) treatment, at which point it was 204 
7.0-fold of the control level. The level of Nrf2 in the nucleus started to decrease after 12 h. 205 
However, at 24 h the Nrf2 level was still 3.7-fold that of the control (Fig. 2B).  206 
 207 
 208 
3.3. Effect of SFN and/or Se on TrxR-1 expression 209 
SFN induced TrxR-1 expression in a dose-dependent manner in CCD841 cells. These data 210 
are consistent with previous publications on tumor cell lines such as colon cancer Caco-2 211 
and breast cancer MCF-7 cells [34, 35]. The effect of SFN and/or Se on TrxR-1 protein 212 
expression in CCD841 was determined using Western blot analysis. A dose-dependent 213 
response was observed in cells exposed to 2.5-20µM SFN (with 0.1% DMSO only as 214 
control) (Fig. 3A). Co-treatment with SFN (2.5µM) and Se (0.1µM) produced a synergistic 215 
effect especially after 24 and 48 h. 2.5µM SFN alone induced TrxR-1 1.8-fold, and Se (0.1 216 
µM) alone induced it 1.4-fold, whereas the combination of 2.5μM SFN and Se (0.1μM) 217 
induced it 3.3-fold. (Fig. 3B). Moreover, co-treatment with 10μM SFN and Se (0.1µM) also 218 
produced a synergistic effect, especially after 24 and 48 h. 10µM SFN alone induced TrxR-219 
1 3.7- and 2.6-fold at 24 and 48 h respectively, Se (0.1 µM) alone induced it 1.9- and 1.5-220 
fold at 24 and 48 h respectively, whereas the combination of 10μM SFN and Se (0.1μM) 221 
induced it 4.3- and 4.0-fold at 24 and 48 h respectively (Fig. 3C). 222 
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 223 
3.4. Protective effect of SFN and/or Se against H2O2-induced cell death 224 
Hydrogen peroxide is known to activate the mitochondrial apoptotic pathway, to decrease 225 
Nrf2 expression, and to increase reactive oxygen species (ROS) levels, leading to cell death 226 
[36]. CCD841 cells were cultured in 96-well plates (seeding 5.0×103 cells per well) and 227 
when they reached 70-80% confluence they were treated with a concentration series (0-228 
1600µM) of H2O2 for 24 h. The IC50 value of H2O2 for CCD841 cells was 64.1µM. 100µM 229 
H2O2 treatment decreased cell viability to 11.4% of the control (Fig. 4). Pre-treatment with 230 
SFN at 2.5 or 5µM for 24 h significantly protected against the reduction in cell viability 231 
induced by 100µM H2O2. Following 2.5 and 5μM SFN pre-treatment, the 100μM H2O2 232 
treatment only reduced cell viabilities to 18.9 and 21.6% respectively. When the cells were 233 
pre-treated with 0.1 and 0.2μM Se for 24 h, the 100μM H2O2 treatment only reduced cell 234 
viabilities to 36 and 35% respectively. For cells that were co-treated with 2.5µM SFN and 235 
0.1µM Se, or with 5µM SFN and 0.2µM Se, subsequent 100µM H202 treatment only 236 
reduced cell viabilities to 61.8 or 56.1% respectively. Moreover, in a separate experiment 237 
using siRNA to knockdown TrxR-1 or Nrf2, the protection afforded by pre-treatment with 238 
SFN (2.5µM) and Se (0.1µM) against the induction of apoptosis by 150µM H2O2 treatment 239 
was reduced such that the proportion of viable cells as indicated by Annexin V/PI staining 240 
was reduced from 82.4% in transfection negative controls, to 66 or 51% in TrxR-1 or Nrf2 241 
knockdowns, respectively (Fig. 5A). This suggests that Nrf2 and TrxR-1 play important 242 
roles in SFN-mediated protection against H2O2-induced cell death in normal colonic cells. 243 
H2O2 caused a concomitant rise in early (single positive) and late stage (double positive) 244 
apoptotic cells as indicated by Annexin V/PI staining. H2O2 induced a 59.9% proportion of 245 
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apoptotic cells; co-treatment with SFN and Se reduced the proportion of apoptotic cells to 246 
13.0% (Fig. 5A). The siRNA knockdown of either TrxR-1 or Nrf2 abrogated the protection 247 
afforded by SFN and Se co-treatment, and increased the apoptotic cell population to 25.4 or 248 
44.9% respectively, suggesting that Nrf2 signaling is important in the protection against free 249 
radical-mediated apoptosis in normal colonic cells. 250 
251 
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4. Discussion 252 
Oxidative stress is one of the most critical factors implicated in many gastrointestinal 253 
diseases, including inflammatory bowel disease and colon cancer [37]. Many selenoproteins 254 
including TrxR-1 are involved in cellular homeostasis and protecting normal and tumor cells 255 
against oxidative stress [38]. Fruits and vegetables are rich in various antioxidants. 256 
Increasing the consumption of fruits and vegetables may inhibit certain cancers [39]. 257 
Although the results from many epidemiological studies are inconsistent and inconclusive, 258 
one exception is the Netherlands Cohort Study on Diet and Cancer, in which women (but 259 
not men) who had a high intake of cruciferous vegetables were shown to have a reduced risk 260 
of colon cancer [3]. Cruciferous vegetables are rich sources of glucosinolates, which can be 261 
broken down to ITCs under the action of myrosinases when the plant tissue is damaged or 262 
cooked. Several studies have demonstrated that dietary ITCs possess significant cancer 263 
chemopreventive potential [24]. However, ITCs have been shown to exert both 264 
chemopreventive and oncogenic activities. Overexpression of Nrf2 and/or TrxR-1 in cancer 265 
cells might be undesirable; high constitutive levels of Nrf2 occur in many tumors and can 266 
promote chemoresistance [13]. On the other hand, the induction of Nrf2 and TrxR-1 by ITCs 267 
in normal cells could be beneficial in cancer prevention [29]. There are over 1000 genes 268 
driven by Nrf2, many of which possess antioxidant or chemopreventive potential [40, 41]. 269 
Apart from TrxR-1, other enzymes such as glutathione transferases (GSTs), quinone 270 
reductase (QR) and heme oxygenase (HO-1) might also be involved in chemoprevention 271 
[42, 43]. GSTs are key enzymes in the metabolism of ITCs in cells. A recent comprehensive 272 
meta-analysis demonstrated an increased cancer risk in Caucasian populations conferred by 273 
GSTM1 and GSTT1 null genotypes [44]. Conversely, results from another study reveal 274 
statistically significant protective effects of crucifer consumption against colorectal 275 
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neoplasms that is stronger among individuals with a single null GSTT1 genotype [45]. To 276 
better understand the mechanisms behind the role of Nrf2 in the chemoprevention of 277 
colorectal cancer, more studies, especially into the genetic aspects of responses to ITCs, are 278 
required. 279 
     The upregulation of antioxidant enzymes by ITCs is one of the most important factors 280 
in chemoprevention. TrxR-1 is an important Se-dependent enzyme involved in the 281 
regulation of cell redox [46]. Similarly to Nrf2 activation, TrxR-1 induction may protect 282 
against carcinogenesis in normal cells, but TrxR-1 overexpression has been reported in a 283 
large number of human tumors [15]. A very recent study suggested that both TrxR-1 and 284 
15kDa selenoprotein (Sep15) participate in interfering regulatory pathways in colon cancer 285 
cells [38]. The relationship between Se and cancer is complex; an optimal intake may 286 
promote health [47]. In general, individuals who have low serum Se levels may benefit from 287 
Se supplementation, but those with high serum Se levels are at increased risk for other 288 
diseases [48]. The cancer-preventive properties of Se in colon cancer are believed to be 289 
mediated by both selenoproteins and low molecular weight selenocompounds [49]. 290 
Although TrxR-1 has been suggested as a novel target for cancer therapy [50], the function 291 
of TrxR-1 in tumor cell growth, migration and invasion warrants further in vitro and in vivo 292 
studies. 293 
     In the present study, we have demonstrated that SFN can activate the Nrf2 signaling 294 
pathway and interact with Se in the upregulation of TrxR-1 in normal colonic cells. Co-295 
treatment of colonic cells with SFN and Se resulted in a synergistic induction of TrxR-1 296 
expression, and provided a greater protective effect against hydrogen peroxide-induced cell 297 
death than treatments with either component individually. An optimal combination of Se and 298 
 16 
SFN may be able to achieve the same level of gene expression using relative less 299 
concentration of each compound than when they are used alone. A limitation of this study is 300 
that the synergy was identified in in vitro cell cultures. Further in vivo studies could consider 301 
positive interactions between bioactives and nutrients to test if they result in greater 302 
protection against oxidative stress and stronger chemopreventive activities. It would be 303 
interesting to identify more synergistic or antagonistic interactions between food 304 
components and whole foods, to help inform healthy dietary recommendations. An optimal 305 
combination of different bioactive phytochemicals, vitamins and minerals may be able to 306 
upregulate chemoprotective enzymes, reduce oxidative stress and improve gut health. In 307 
conclusion, combined SFN and Se treatment synergistically upregulated TrxR-1, which 308 
plays a significant role in maintaining intracellular redox homeostasis and contributed to the 309 
SFN-induced protection against free radical-mediated oxidative damage in normal colonic 310 
cells.311 
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Figure legends 456 
 457 
Fig. 1. Effect of SFN on CCD841 cell growth. 458 
Cells at 70–80% confluence were treated with SFN (0-160μM) in cell culture medium for 459 
24-48 h. Control cells were treated with DMSO (0.1%) only. Cell viability was determined 460 
by the MTT cell proliferation assay. Each data point represents the means ± SD (n=5). *, 461 
P<0.05; **P<0.01.  462 
 463 
Fig. 2 Effect of SFN on the translocation of Nrf2 into the nucleus.  464 
CCD841 cells were exposed to SFN (with DMSO (0.1%) only as control). Nuclear protein 465 
fractions were isolated as described in Methods and materials. Nrf2 was detected and 466 
quantified by Western blot analysis. Nrf2 band densities were normalized against Sam68 (68 467 
kDa), and results were expressed as fold induction relative to controls. Data are expressed as 468 
means ± SD (n=3). (A) Dose-response, SFN (0-40µM) for 4 h. (B) Time course, SFN 469 
(10µM) for 0-48 h. *, P<0.05; **P<0.01. 470 
 471 
Fig. 3. Effect of SFN on TrxR-1 protein expression.  472 
CCD841 cells were exposed to SFN (2.5-40µM) for 24 h (DMSO (0.1%) only was used as a 473 
control) (A). Synergistic effect of SFN with Se: dose response (B), and time response (C). 474 
Folds of change were determined by Western blot analysis, from the average TrxR-1 band 475 
densities (normalized to those of β-actin). Data are expressed as means ± SD (n=3). *, 476 
P<0.05; **P<0.01. 477 
 478 
 24 
Fig. 4. Effect of co-treatment with SFN and Se on H2O2-induced cell death.  479 
CCD841 cells were cultured in 96-well plates (seeding 7.0 × 103 cells per well) and when 480 
they reached 70-80% confluence, were pre-treated with SFN (2.5 or 5µM) (or DMSO (0.1%) 481 
only as control) and/or Se (0.1 or 0.2µM) for 24 h, and were then exposed to H2O2 (100μΜ) 482 
in serum-free medium for further 24 h. Cell viability was measured by the MTT assay. *, 483 
P<0.05; **P<0.01. 484 
 485 
Fig. 5. Effect of siRNA knockdown of TrxR-1 and Nrf2 on the protection against H2O2-486 
induced cell death mediated by SFN and Se co-treatment.  487 
CCD841 cells were pre-treated with SFN (2.5µM) and Se (0.1µM) for 24 h, then siRNA 488 
(20nM) knockdown of TrxR-1 or Nrf2 (with AllStars Negative Control siRNA (AS) as 489 
negative control) was performed. Then the cells were exposed to H2O2 (100μΜ) for 24 h. The 490 
cells were then stained with Annexin V and PI, and flow cytometric analysis was carried out. 491 
The H2O2-treated cells have a higher percentage of apoptotic cells (Annexin V positive), as 492 
indicated by the percentage of gated cells (B). SFN and Se pre-treatment afforded significant 493 
protection against H2O2; siRNA against TrxR-1 or Nrf2 abrogated this protection. Early and 494 
late apoptotic data (red bars) are expressed as means ± SD (n=3). *P<0.05; **P<0.01 in 495 
comparison to the AS control. 496 
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